Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-27 @ 11:58 PM
Study NCT ID:
NCT01194960
Status:
TERMINATED
Last Update Posted:
2020-10-19
First Post:
2010-09-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Sponsor:
Oxford BioMedica
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-08
Start Date Type:
None
Primary Completion Date:
2013-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-02
First Submit QC Date:
None
Study First Post Date:
2010-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-10-08
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-10-08
Last Update Post Date:
2020-10-19
Last Update Post Date Type:
ACTUAL